4Dmedical Historical Income Statement

4DX Stock

0.48 0.02 4.35%

Historical analysis of 4Dmedical income statement accounts such as Total Revenue of 4.5 M, Gross Profit of 4.2 M or Other Operating Expenses of 19.4 M can show how well 4Dmedical performed in making a profits. Evaluating 4Dmedical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of 4Dmedical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining 4Dmedical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 4Dmedical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About 4Dmedical Income Statement Analysis

4Dmedical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to 4Dmedical shareholders. The income statement also shows 4Dmedical investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

4Dmedical Income Statement Chart

At this time, 4Dmedical's Depreciation And Amortization is comparatively stable compared to the past year. Total Revenue is likely to gain to about 4.5 M in 2025, despite the fact that EBIT is likely to grow to (30.7 M).

Depreciation And Amortization Operating Income Ebit Ebitda Tax Provision

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Operating Income

Operating Income is the amount of profit realized from 4Dmedical operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of 4Dmedical is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most accounts from 4Dmedical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into 4Dmedical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in 4Dmedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2022	2023	2024	2025 (projected)
Total Revenue	282.2K	3.8M	4.3M	4.5M
Depreciation And Amortization	2.6M	4.1M	4.7M	4.9M

Total Revenue Depreciation And Amortization

4Dmedical income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Interest Expense	Selling General Administrative	Income Tax Expense	Interest Income	Research Development	Net Interest Income	Selling And Marketing Expenses	Net Income From Continuing Ops	Reconciled Depreciation
Depreciation And Amortization		0.92	0.64	0.73	-0.76	-0.84	-0.81	-0.22	0.85	-0.9	-0.83	-0.88	-0.08	0.98	-0.81	0.12	-0.5	0.96	0.84	-0.96	0.92
Total Revenue	0.92		0.55	0.5	-0.57	-0.66	-0.63	-0.07	0.62	-0.78	-0.87	-0.73	0.0	0.88	-0.94	0.2	-0.67	0.83	0.59	-0.84	0.84
Gross Profit	0.64	0.55		0.3	-0.3	-0.39	-0.36	-0.87	0.51	-0.38	-0.43	-0.35	-0.64	0.54	-0.58	-0.5	-0.57	0.66	0.53	-0.66	0.64
Other Operating Expenses	0.73	0.5	0.3		-0.97	-0.96	-0.97	-0.06	0.95	-0.9	-0.59	-0.93	0.12	0.82	-0.28	0.23	0.14	0.81	0.85	-0.72	0.73
Operating Income	-0.76	-0.57	-0.3	-0.97		0.99	1.0	0.02	-0.95	0.92	0.64	0.94	-0.14	-0.86	0.33	-0.26	-0.12	-0.84	-0.81	0.74	-0.69
Ebit	-0.84	-0.66	-0.39	-0.96	0.99		1.0	0.07	-0.97	0.96	0.7	0.97	-0.09	-0.91	0.44	-0.23	0.0	-0.9	-0.86	0.82	-0.77
Ebitda	-0.81	-0.63	-0.36	-0.97	1.0	1.0		0.06	-0.97	0.95	0.68	0.96	-0.11	-0.9	0.4	-0.24	-0.04	-0.88	-0.85	0.79	-0.75
Cost Of Revenue	-0.22	-0.07	-0.87	-0.06	0.02	0.07	0.06		-0.24	-0.01	0.0	-0.02	0.76	-0.13	0.14	0.71	0.28	-0.29	-0.29	0.29	-0.27
Total Operating Expenses	0.85	0.62	0.51	0.95	-0.95	-0.97	-0.97	-0.24		-0.92	-0.65	-0.93	-0.02	0.91	-0.4	0.12	-0.03	0.9	0.91	-0.83	0.76
Income Before Tax	-0.9	-0.78	-0.38	-0.9	0.92	0.96	0.95	-0.01	-0.92		0.85	1.0	-0.22	-0.96	0.61	-0.38	0.2	-0.89	-0.81	0.87	-0.83
Total Other Income Expense Net	-0.83	-0.87	-0.43	-0.59	0.64	0.7	0.68	0.0	-0.65	0.85		0.82	-0.31	-0.84	0.8	-0.48	0.55	-0.7	-0.47	0.74	-0.75
Net Income	-0.88	-0.73	-0.35	-0.93	0.94	0.97	0.96	-0.02	-0.93	1.0	0.82		-0.24	-0.94	0.54	-0.39	0.13	-0.87	-0.81	0.85	-0.8
Interest Expense	-0.08	0.0	-0.64	0.12	-0.14	-0.09	-0.11	0.76	-0.02	-0.22	-0.31	-0.24		0.05	0.09	0.98	0.28	-0.19	-0.19	0.17	-0.16
Selling General Administrative	0.98	0.88	0.54	0.82	-0.86	-0.91	-0.9	-0.13	0.91	-0.96	-0.84	-0.94	0.05		-0.72	0.23	-0.34	0.96	0.86	-0.93	0.88
Income Tax Expense	-0.81	-0.94	-0.58	-0.28	0.33	0.44	0.4	0.14	-0.4	0.61	0.8	0.54	0.09	-0.72		-0.1	0.84	-0.69	-0.41	0.77	-0.79
Interest Income	0.12	0.2	-0.5	0.23	-0.26	-0.23	-0.24	0.71	0.12	-0.38	-0.48	-0.39	0.98	0.23	-0.1		0.13	-0.01	-0.04	-0.02	0.02
Research Development	-0.5	-0.67	-0.57	0.14	-0.12	0.0	-0.04	0.28	-0.03	0.2	0.55	0.13	0.28	-0.34	0.84	0.13		-0.31	-0.05	0.45	-0.48
Net Interest Income	0.96	0.83	0.66	0.81	-0.84	-0.9	-0.88	-0.29	0.9	-0.89	-0.7	-0.87	-0.19	0.96	-0.69	-0.01	-0.31		0.91	-0.96	0.91
Selling And Marketing Expenses	0.84	0.59	0.53	0.85	-0.81	-0.86	-0.85	-0.29	0.91	-0.81	-0.47	-0.81	-0.19	0.86	-0.41	-0.04	-0.05	0.91		-0.87	0.8
Net Income From Continuing Ops	-0.96	-0.84	-0.66	-0.72	0.74	0.82	0.79	0.29	-0.83	0.87	0.74	0.85	0.17	-0.93	0.77	-0.02	0.45	-0.96	-0.87		-0.92
Reconciled Depreciation	0.92	0.84	0.64	0.73	-0.69	-0.77	-0.75	-0.27	0.76	-0.83	-0.75	-0.8	-0.16	0.88	-0.79	0.02	-0.48	0.91	0.8	-0.92

Click cells to compare fundamentals

4Dmedical Account Relationship Matchups

4Dmedical income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	741.5K	1.5M	2.6M	4.1M	4.7M	4.9M
Total Revenue	217.0K	1.1M	282.2K	3.8M	4.3M	4.5M
Gross Profit	125.1K	280.6K	248.0K	3.5M	4.0M	4.2M
Other Operating Expenses	24.6M	37.8M	45.3M	31.7M	36.5M	19.4M
Operating Income	(18.8M)	(36.8M)	(31.1M)	(28.0M)	(25.2M)	(23.9M)
Ebit	(18.8M)	(37.8M)	(36.3M)	(35.9M)	(32.3M)	(30.7M)
Ebitda	(18.0M)	(36.3M)	(33.7M)	(31.9M)	(28.7M)	(27.2M)
Cost Of Revenue	91.9K	773.7K	34.1K	236.7K	213.0K	202.4K
Total Operating Expenses	24.5M	37.0M	45.3M	31.5M	36.2M	38.0M
Income Before Tax	(21.4M)	(24.5M)	(31.1M)	(40.4M)	(36.4M)	(34.5M)
Total Other Income Expense Net	(7.7M)	(2.3M)	(483.2K)	(12.4M)	(11.2M)	(10.6M)
Net Income	(21.4M)	(24.6M)	(31.5M)	(36.0M)	(32.4M)	(30.8M)
Tax Provision	15.3K	43.2K	323.2K	48.4K	55.7K	60.0K
Interest Expense	2.6M	179.6K	6.5K	264.0K	237.6K	225.7K
Selling General Administrative	11.7M	19.8M	23.2M	28.8M	33.1M	34.7M
Net Income Applicable To Common Shares	(22.0M)	(21.4M)	(24.6M)	(31.5M)	(28.3M)	(26.9M)
Income Tax Expense	15.3K	43.2K	323.2K	(4.4M)	(4.0M)	(3.8M)
Interest Income	2.7M	92.6K	313.6K	1.2M	1.1M	1.4M
Research Development	2.4M	4.4M	4.0M	694.5K	625.0K	593.8K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for 4Dmedical Stock Analysis

When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC